Cleared Traditional

K910178 - ACTH IRMA KIT MITSUBISHI YUKA

K910178 is an FDA 510(k) clearance for ACTH IRMA KIT MITSUBISHI YUKA, manufactured by Science Regulatory Services Intl.. The device is a Class 2 Chemistry device with product code CKG cleared through the Traditional 510(k) pathway after a 127-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1991
Decision
127d
Days
Class 2
Risk

K910178 is an FDA 510(k) clearance for the ACTH IRMA KIT MITSUBISHI YUKA. Classified as Radioimmunoassay, Acth (product code CKG), Class II - Special Controls.

Submitted by Science Regulatory Services Intl. (Washington, US). The FDA issued a Cleared decision on May 22, 1991 after a review of 127 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1025 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K910178

510(k) Number K910178 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 15, 1991
Decision Date May 22, 1991
Days to Decision 127 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
38d slower than avg
Panel avg: 89d · This submission: 127d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CKG Device Classification - Class 2, Special Controls

Product Code CKG Radioimmunoassay, Acth
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CKG Radioimmunoassay, Acth

All 29
Devices cleared under the same product code (CKG) and FDA review panel - the closest regulatory comparables to K910178.
INCSTAR ACTH IRMA
K940271 · Incstar Corp. · Aug 1994
ADRENOCORTICOTROPIC/ACTH ANALYSIS PRODUCT
K926396 · Nichols Institute · Jul 1993
ACTH IRMA KIT II MITSUBISHI YUKA
K915727 · Mitsubishi Yuka America, Inc. · Mar 1992
MODIFIED DSL-2300 ACTH RIA
K900147 · Diagnostic Systems Laboratories, Inc. · Mar 1990
ALLEGRO ACTH IMMUNOASSAY KIT 65 AND 130 TUBES
K882741 · Nichols Institute Diagnostics · Aug 1988
ACTHK-PR RIA KIT
K860311 · Compagnie Oris Industrie, S.A. · Apr 1986